AUROBINDO FINASTERIDE finasteride 1 mg tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Nopērc to tagad

Aktīvā sastāvdaļa:

finasteride, Quantity: 1 mg

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Finasteride

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: microcrystalline cellulose; magnesium stearate; lactose monohydrate; docusate sodium; pregelatinised maize starch; sodium starch glycollate type A; titanium dioxide; hypromellose; hyprolose; purified talc; iron oxide yellow; iron oxide red

Ievadīšanas:

Oral

Vienības iepakojumā:

28, 30

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

AUROBINDO FINASTERIDE is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. Efficacy has not been demonstrated in men over the age of 41 years. AUROBINDO FINASTERIDE is not indicated for use in women (see Use in Pregnancy and Clinical Studies) or children.

Produktu pārskats:

Visual Identification: Brown colored, film coated, biconvex, octagonal shaped tablets, debossed with 'J' on side and '81' on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2014-04-30